In last trading session, Mersana Therapeutics Inc (NASDAQ:MRSN) saw 2.86 million shares changing hands with its beta currently measuring 0.82. Company’s recent per share price level of $0.32 trading at -$0.03 or -7.33% at ring of the bell on the day assigns it a market valuation of $40.51M. That closing price of MRSN’s stock is at a discount of -784.38% from its 52-week high price of $2.83 and is indicating a premium of 18.75% from its 52-week low price of $0.26. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.63 million shares which gives us an average trading volume of 2.70 million if we extend that period to 3-months.
For Mersana Therapeutics Inc (MRSN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.29. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Mersana Therapeutics Inc (NASDAQ:MRSN) trade information
Upright in the red during last session for losing -7.33%, in the last five days MRSN remained trading in the red while hitting it’s week-highest on Monday, 06/23/25 when the stock touched $0.32 price level, adding 13.19% to its value on the day. Mersana Therapeutics Inc’s shares saw a change of -85.29% in year-to-date performance and have moved -8.73% in past 5-day. Mersana Therapeutics Inc (NASDAQ:MRSN) showed a performance of -9.72% in past 30-days. Number of shares sold short was 15.07 million shares which calculate 4.92 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 3 to the stock, which implies a rise of 89.33% to its current value. Analysts have been projecting 3 as a low price target for the stock while placing it at a high target of 3. It follows that stock’s current price would drop -837.5% in reaching the projected high whereas dropping to the targeted low would mean a loss of -837.5% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 2.74% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -6.99% while estimates for its earnings growth in next 5 years are of -8.65%.
Mersana Therapeutics Inc (NASDAQ:MRSN)’s Major holders
Insiders are in possession of 1.48% of company’s total shares while institution are holding 72.21 percent of that, with stock having share float percentage of 73.29%. Investors also watch the number of corporate investors in a company very closely, which is 72.21% institutions for Mersana Therapeutics Inc that are currently holding shares of the company. ECOR1 CAPITAL, LLC is the top institutional holder at MRSN for having 19.36 million shares of worth $38.92 million. And as of 2024-06-30, it was holding 15.8156 of the company’s outstanding shares.
The second largest institutional holder is VR ADVISER, LLC, which was holding about 11.33 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.2519 of outstanding shares, having a total worth of $22.77 million.
